Cite
MLA Citation
Roy S Herbst et al.. “Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.” Lancet oncology, vol. 20, no. 8, 2019, pp. 1109–1123. http://access.bl.uk/ark:/81055/vdc_100088832694.0x00000a